Primary Stenting for Acute Myocardial Infarction

J. Peter; A. Yhip; Richard W. Smalling

doi:10.1055/s-0037-1615576

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1999; 82(S 01): 160-163
DOI: 10.1055/s-0037-1615576

Commentaries

Schattauer GmbH

Primary Stenting for Acute Myocardial Infarction

J. Peter

¹From the University of Texas Medical School at Houston and the Hermann Heart Center, Houston, Texas

,

A. Yhip

¹From the University of Texas Medical School at Houston and the Hermann Heart Center, Houston, Texas

,

Richard W. Smalling

¹From the University of Texas Medical School at Houston and the Hermann Heart Center, Houston, Texas

› Institutsangaben

Abstract

Summary

Primary stenting for acute MI has been shown to be an improvement over PTCA alone. As with primary PTCA however there is an obligate delay in restoration of TIMI flow due to the time necessary for mobilization of the cath lab team. It is possible that a hybrid approach using partial thrombolysis plus early IIB/IIIA inhibitor administration followed by urgent angiography and stenting of the culprit lesion will be the ideal approach.

Key words

Stenting - PTCA - revascularisation

Volltext

Referenzen

References
1 Chesebro JH, Knatterud G, Roberts R. et al. Thombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
2 The GUSTO, Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
3 Anonymous An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
4 Smalling RW, Bode C, Kalbfleisch J. et al. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 1995; 91: 2725-32.
5 Fujise K, Revelle BM, Stacy L, Madison EL, Yeh ETH, Willerson JT, Beck PJ. A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. Circulation 1997; 95: 715-22.
6 GUSTO III Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118-23.
7 White HD, French JK, Hamer AW, Brown MA, Williams BF, Ormiston JA, Cross DB. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effects of antiplatelet therapy. J Am Coll Cardiol 1995; 25: 218-23.
8 Grines CL, Browne KR, Marco J. et al. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
9 Zijlstra F, DeBoer MJ, Hoorntje JCA. et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
10 Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative (metaanalysis) of the randomized clinical trials. Circulation 1995; 91: 476-85.
11 Grassman ED, Johnson SA, Krone RJ. Predictors of success and major complications for primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. An analysis of the 1990 to 1994 Society for Cardiac Angiography and Interventions registries. J Am Coll Cardiol 1997; 30 (1) 201-8.
12 Stone GW, Grines CL, Browne KF. et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary coronary angioplasty. J Am Coll Cardiol 1995; 26: 66-72.
13 O'Neill WW, Weintraub R, Grines CL. et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation 1992; 86: 1710-7.
14 Brodie BR, Grines CL, Ivanhoe R. et al. Six-month clinical and angio-graphic follow-up after direct angioplasty for acute myocardial infarction. Circulation 1994; 25: 156-62.
15 Feld S, Ganim M, Carrell ES, Kjellgren O, Kirkeeide RL, Vaughn WK, Kelly R, McGhie AI, Kramer N, Loyd D, Anderson HV, Schroth G, Smalling RW. Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. J Am Coll Cardiol 1996; 28: 97-105.
16 Van Belle E, Lablanche JM, Bauters C, Renaud N, McFadden EP, Bertrand ME. Coronary angioscopic findings in the infarct-related vessel within one month of acute myocardial infarction: Natural history and the effect of thrombolysis. Circulation 1998; 97: 26-33.
17 Agrawal SK, Ho DSV, Liu MW, Iyer S, Hearn JA, Cannon AD, Macander PJ, Dean LS, Baxley WA, Roubin GS. Predictors of thrombotic complications after placement of a flexible coil stent. Am J Cardiol 1994; 73: 1216-9.
18 Alfonso F, Rodriguez P, Phillips P. et al. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol 1997; 29: 725-33.
19 Schomig A, Neumann FJ, Walter H, Schulen H, Hadamitzky M, Zitzmann-Roth EM, Dirschinger J, Hausleiter J, Blasini R, Schmitt C, Alt E, Kastrati A. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997; 29: 28-34.
20 Schuhlen H, Hadamitzky M, Walter H, Ulm K, Schomig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial. Circulation 1997; 95: 2015-21.
21 Nakamura S, Colombo A, Gaglione A. Intracoronary ultrasound observations during stent implantation. Circulation 1994; 89 (5) 2026-34.
22 Serruys PW, de Jaegere P, Kiemeneij F. et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
23 Fischman DL, Leon MB, Baim DS. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
24 Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997; 336: 817-22.
25 Van Belle E, Bauters C, Hubert E. et al. Restenosis rates in diabetic patients. Circulation 1997; 96: 1454-60.
26 Savage MP, Douglas Jr JS, Fischman DL. et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997; 337: 740-7.
27 Rubartelli P, Niccoli L, Verna E. et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the GISSOC Trial. J Am Coll Cardiol 1998; 32: 90-6.
28 Antoniucci D, Valenti R, Giovanni M. et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: In-hospital and long-term survival. J Am Coll Cardiol 1998; 31: 294-300.
29 Bauters C, Lablanche JM, Van Belle E. et al. Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. Circulation 1997; 96: 2854-8.
30 Mahdi NA, Lopez J, Leon M, Pathan A, Harrell L, Jang IK, Palacios IF. Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction. Am J Cardiol 1998; 81: 957-63.
31 Stone GW, Brodie BR, Griffin JJ. et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angio-plasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998; 31 (1) 23-30.
32 Antoniucci D, Santoro GM, Bolognese L, Velenti R, Trapapni M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 31: 1234-9.
33 Rodriguez A, Bernardi V, Fernandez M. et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 1998; 81: 1286-91.
34 Suryapranata H, van't Hof AWJ, Hoorntje JCA, de Boer M-J, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-5.
35 O'Keefe JH, Rutherford BD, McConahay DR. et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989; 64: 1221-30.
36 Benzuly KH, O'Neill WW, Brodie B, et al. Predictors of maintained infarct arter patency after primary angioplasty in high risk patients in PAMI 2 (abstract). Am Coll Cardiol. 1996 27. (Suppl A) 279A.
37 Khan MM, Ellis SG, Aguirre FV. et al. Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. J Am Coll Cardiol 1998; 31: 31-6.
38 Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIB/IIIa blockade The EPISTENT Investigators. Evaluation of Platelet IIB/IIIa Inhibitor for Stenting. Lancet 1998; 352 (9122) 87-92.